- Home
- CLM vs RXRX Comparison
CLM vs RXRX Comparison
Compare CLM & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLM | RXRX |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLM | RXRX |
|---|---|---|
| Price | $7.49 | $3.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 2.7M | ★ 14.1M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | N/A | $16.50 |
| Revenue Next Year | N/A | $66.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $6.57 | $2.98 |
| 52 Week High | $8.53 | $7.18 |
Technical Indicators
Market Signals| Indicator | CLM | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 41.20 |
| Support Level | $7.05 | $2.98 |
| Resistance Level | $8.29 | $5.12 |
| Average True Range (ATR) | 0.16 | 0.20 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 29.71 | 21.51 |
Price Performance
Historical ComparisonAbout CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.